CA Patent

CA3242815A1 — SALT FORM AND CRYSTAL FORM OF COMPLEMENT FACTOR B INHIBITOR, CORRESPONDING PREPARATION METHOD AND ASSOCIATED USE

Assigned to Shanghai Meiyue Biotech Development Co Ltd · Expires 2023-08-03 · 3y expired

What this patent protects

A pharmaceutically acceptable salt type and crystal form of a compound as represented by the following formula (I), and a preparation method of the compound and an application thereof.

USPTO Abstract

A pharmaceutically acceptable salt type and crystal form of a compound as represented by the following formula (I), and a preparation method of the compound and an application thereof.

Drugs covered by this patent

Patent Metadata

Patent number
CA3242815A1
Jurisdiction
CA
Classification
—
Expires
2023-08-03
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Meiyue Biotech Development Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.